Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Marts 2022

Genmab — Marts 2022

Planlagt Fastgjort Låst Flyttet Genmab
555 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • DarvinD Offline
    DarvinD Offline
    Darvin
    wrote on sidst redigeret af
    #40

    Og m.h.t. udløb af Royalty defineres det “expiring on the later of: (i) thirteen (13) years thereafter; or (ii) the expiration (such expiration to occur only after expiration of extensions of any nature to such patents which may be obtained under applicable statutes or regulations in the respective countries”. Enhver tænkelig forlængelse af patent.

    1 Reply Last reply
    0
    • DarvinD Offline
      DarvinD Offline
      Darvin
      wrote on sidst redigeret af
      #41

      Hvis jeg var dommer ville jeg ikke være i tvivl om at SC udviklingen var forventet og forventelig, og at det er en fuldkommen alm. videreførelse af patentet (Genmab’s). Altså glem patentbortfald JJ.

      1 Reply Last reply
      0
      • DarvinD Offline
        DarvinD Offline
        Darvin
        wrote on sidst redigeret af
        #42

        Jeg er mere i tvivl om hvorvidt Genmab kan undgå at betale en del af royalty til Halo. Som Bulder skriver er det jo en licens. Men det er så absolut det mindste, og mere end rigeligt indregnet i dagens kurs.

        1 Reply Last reply
        0
        • DarvinD Offline
          DarvinD Offline
          Darvin
          wrote on sidst redigeret af
          #43

          Jeg tror mere at JJ’s fremførelse er, at hvis ikke Genmab mener de skal dele omkostningen, ja - så syntes de jo nok at Halo og SC er dem uvedkommende. I givet fald bortfalder patentforlængelsen - som ellers er beskrevet. Altså et slag i luften, og et ynkeligt forsøg på at bortlede opmærksomheden fra facts.

          1 Reply Last reply
          0
          • G Offline
            G Offline
            gentogen
            wrote on sidst redigeret af
            #44

            Tak Darvin. Helt enig. Det ville jo også være totalt bindegalt, hvis de havde en kontrakt på, at de kunne tilsætte lidt postevand til Dara og derefter overtage alle rettigheder.

            1 Reply Last reply
            0
            • P Offline
              P Offline
              ProinvestorNEWS
              wrote on sidst redigeret af
              #45

              OVERBLIK: Første fald til C25 siden krigsudbrud og atomtrussel - NY
              https://www.proinvestor.com/investornyt/788899/overblik-forste-fald-til-c25-siden-krigsudbrud-og-atomtrussel-ny

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #46

                Horizon Therapeutics plc Reports Fourth-Quarter 2021 and Full-Year 2021

                • TEPEZZA Net Sales of $1.66 Billion, Representing Year-Over-Year Growth of 103% - 2022 Guidance - Expect TEPEZZA Net Sales Percentage Growth in the Mid-30s https://ir.horizontherapeutics.com/static-files/ebc13715-b2f2-4ada-be08-e9c2bfd1badb
                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #47

                  They estimated 1,625 so it's better.

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #48

                    And genmab will get a little under 100 mio $

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #49

                      yes, i estimated it wrong, last year i calculated 5.94% royalty; to get to the dkk593mn royalty with 5.94% they would have to use fx rate of ~6.02 which can not be correct, need to look into that

                      1 Reply Last reply
                      0
                      • nohopeN Offline
                        nohopeN Offline
                        nohope
                        wrote on sidst redigeret af
                        #50

                        Why not 6,02 ?Sometimes they use fixed USD/DKK - if contract was closed like 3 years ago then it could have been 6,02

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          ProinvestorNEWS
                          wrote on sidst redigeret af
                          #51

                          Genmab Announces Appointments of Birgitte Stephensen to Chief Legal Officer and Chris Cozic to Chief People Officer https://proinvestor.com/investornyt/788995/genmab-announces-appointments-of-birgitte-stephensen-to-chief-legal-officer-and-chris-cozic-to-chief-people-officer

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #52

                            I don't think they get paid in dkk, but in usd. And then Genmab has to translate that usd amount into dkk for the annual report (or actually sell the $ for dkk if they need to) at prevailing market rates

                            1 Reply Last reply
                            0
                            • BulderB Offline
                              BulderB Offline
                              Bulder
                              wrote on sidst redigeret af
                              #53

                              Når de forfremmer patent-direktøren, er det så fordi de har vundet patentsagen?

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #54

                                😉

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  ProinvestorNEWS
                                  wrote on sidst redigeret af
                                  #55

                                  Genmab udnævner to nye koncerndirektører https://proinvestor.com/investornyt/789019/genmab-udnaevner-to-nye-koncerndirektorer

                                  1 Reply Last reply
                                  0
                                  • SolsenS Offline
                                    SolsenS Offline
                                    Solsen
                                    wrote on sidst redigeret af
                                    #56

                                    På kursudviklingen kunne det tyde på det 🙂

                                    1 Reply Last reply
                                    0
                                    • SolsenS Offline
                                      SolsenS Offline
                                      Solsen
                                      wrote on sidst redigeret af
                                      #57

                                      Var SBs target ikke 2317 ddk her omkring 1. Marts. Meget godt ramt !

                                      1 Reply Last reply
                                      0
                                      • SolsenS Offline
                                        SolsenS Offline
                                        Solsen
                                        wrote on sidst redigeret af
                                        #58

                                        Det køb af 5xbull ser ud til at være fornuftigt indtil videre. Hvis JNJ taber hele sagen har vi et bud på Genmab….

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          ProinvestorNEWS
                                          wrote on sidst redigeret af
                                          #59

                                          USA/åbning: Aktierne retter sig - mindre tro på markant renteløft https://proinvestor.com/investornyt/789052/usa-abning-aktierne-retter-sig-mindre-tro-pa-markant-renteloft

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper